Embedding European Pharmacopoeia mRNA Standards into CMC & Process Strategies to Ensure Harmonised Quality

• Adapting test methods, acceptance criteria and reference standards to meet European Pharmacopoeia expectations without overburdening development resources
• Assessing how evolving European Pharmacopoeia content interacts with MHRA, EMA and other agency expectations to build a coherent, Europe-ready CMC framework

Speakers:

Ioannis Rabias

Head of QC

European Directorate for the Quality of Medicines & HealthCare